Literature DB >> 7520728

Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse.

D M Magee1, J U Igietseme, J G Smith, C A Bleicker, B G Grubbs, J Schachter, R G Rank, D M Williams.   

Abstract

We have developed a model of pneumonia caused by the mouse pneumonitis agent (MoPn, murine Chlamydia trachomatis) in the C.B-17 severe combined immunodeficiency (SCID) mouse. In contrast to our prior models in the nude athymic (nu/nu) and heterozygous (nu/+) mouse, SCID mice lack B-cell function and gamma delta T-cell function. SCID mice were more susceptible to MoPn than nu/nu or nu/+ mice both by criteria of mortality and quantitative lung culture. SCID mice could be reconstituted with thymocytes to be more resistant to MoPn (in the absence of significant antibody production), but the protection was modest and less than that in T-cell reconstituted nu/nu mice in our previous studies. A nu/+ MoPn-specific T-cell clone with a Th1-like cytokine profile also provided modest but significant protection without significant antibody production. The SCID mouse is a useful model to study T-cell-mediated immunity to MoPn in a B cell and gamma delta T-cell-deficient environment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7520728

Source DB:  PubMed          Journal:  Reg Immunol        ISSN: 0896-0623


  9 in total

1.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

2.  Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.

Authors:  Sukumar Pal; Jose Bravo; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

3.  Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis.

Authors:  D M Williams; B G Grubbs; E Pack; K Kelly; R G Rank
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Role of CD8 T cells in primary Chlamydia infection.

Authors:  D M Magee; D M Williams; J G Smith; C A Bleicker; B G Grubbs; J Schachter; R G Rank
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

5.  Reemergence of the Murine Bacterial Pathogen Chlamydia muridarum in Research Mouse Colonies.

Authors:  Noah Mishkin; Rodolfo J Ricart Arbona; Sebastian E Carrasco; Samira Lawton; Kenneth S Henderson; Panagiota Momtsios; Ira M Sigar; Kyle H Ramsey; Christopher Cheleuitte-Nieves; Sebastien Monette; Neil S Lipman
Journal:  Comp Med       Date:  2022-07-08       Impact factor: 1.565

6.  Reinfection with Chlamydophila abortus by uterine and indirect cohort routes reduces fertility in cattle preexposed to Chlamydophila.

Authors:  Fred J DeGraves; TeaYoun Kim; JunBae Jee; Tobias Schlapp; Hans-Robert Hehnen; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection.

Authors:  Hongyu Qiu; Jie Yang; Hong Bai; Yijun Fan; Shuhe Wang; Xiaobing Han; Lijun Chen; Xi Yang
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

8.  Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection.

Authors:  Laxmi Yeruva; Nicole Spencer; Anne K Bowlin; Yin Wang; Roger G Rank
Journal:  Pathog Dis       Date:  2013-07-10       Impact factor: 3.166

9.  Th1 cells are dispensable for primary clearance of Chlamydia from the female reproductive tract of mice.

Authors:  Jordan A Rixon; Claire E Depew; Stephen J McSorley
Journal:  PLoS Pathog       Date:  2022-02-23       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.